Innovent Biologics, Inc. (IVBXF)
USD 6.88
(25.23%)
USD 6.88
(25.23%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 6.2 Billion CNY | 36.21% |
| 2022 | 4.55 Billion CNY | 6.71% |
| 2021 | 4.26 Billion CNY | 11.08% |
| 2020 | 3.84 Billion CNY | 266.94% |
| 2019 | 1.04 Billion CNY | 10953.34% |
| 2018 | 9.47 Million CNY | -48.88% |
| 2017 | 18.53 Million CNY | -35.56% |
| 2016 | 28.76 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 548.32 Million USD | 0.0% |
| 2023 Q1 | 196.68 Million USD | -40.9% |
| 2023 FY | 6.2 Billion CNY | 36.21% |
| 2023 Q4 | 484.73 Million USD | 101.97% |
| 2023 Q3 | 240 Million USD | -38.42% |
| 2023 Q2 | 389.76 Million USD | 98.17% |
| 2022 Q2 | 344.53 Million USD | 0.0% |
| 2022 FY | 4.55 Billion CNY | 6.71% |
| 2022 Q4 | 332.77 Million USD | 104.39% |
| 2022 Q3 | 162.81 Million USD | -52.74% |
| 2021 FY | 4.26 Billion CNY | 11.08% |
| 2021 Q4 | 361.3 Million USD | 0.0% |
| 2021 Q2 | 300.02 Million USD | 0.0% |
| 2020 FY | 3.84 Billion CNY | 266.94% |
| 2020 Q4 | 422 Million USD | 0.0% |
| 2020 Q2 | 140.11 Million USD | 0.0% |
| 2019 Q4 | 100.3 Million USD | 0.0% |
| 2019 FY | 1.04 Billion CNY | 10953.34% |
| 2019 Q2 | 51.12 Million USD | 0.0% |
| 2018 FY | 9.47 Million CNY | -48.88% |
| 2017 FY | 18.53 Million CNY | -35.56% |
| 2016 FY | 28.76 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Nuo Therapeutics, Inc. | 608.52 Thousand USD | -1019754.566% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | -1512966.693% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Evofem Biosciences, Inc. | 18.21 Million USD | -33965.594% |
| GB Sciences, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Skye Bioscience, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| Arch Therapeutics, Inc. | 75.72 Thousand USD | -8195544.71% |
| Biomind Labs Inc. | - USD | -Infinity% |
| ContraFect Corporation | - USD | -Infinity% |
| CSL Limited | 14.69 Billion USD | 57.753% |
| CytoDyn Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 1.93 Million USD | -321125.155% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Propanc Biopharma, Inc. | - USD | -Infinity% |
| Regen BioPharma, Inc. | 236.56 Thousand USD | -2623365.506% |
| Santhera Pharmaceuticals Holding AG | 122.95 Million USD | -4947.48% |
| SQZ Biotechnologies Company | 21.47 Million USD | -28795.009% |
| Therapeutic Solutions International, Inc. | 98.99 Thousand USD | -6269037.523% |
| Eiger BioPharmaceuticals, Inc. | 15.77 Million USD | -39246.161% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -9441949.051% |
| Mesoblast Limited | 5.9 Million USD | -105051.982% |
| Marizyme, Inc. | 645.81 Thousand USD | -960874.59% |
| Genus plc | 668.8 Million USD | -827.941% |
| Pharming Group N.V. | 245.31 Million USD | -2429.827% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -8084825.939% |
| IMV Inc. | - USD | -Infinity% |
| AXIM Biotechnologies, Inc. | 39.51 Thousand USD | -15704313.179% |
| MultiCell Technologies, Inc. | 49.32 USD | -12583272406.083% |
| ONE Bio Corp. | 52.29 Million USD | -11767.152% |
| RVL Pharmaceuticals plc | 49.72 Million USD | -12381.788% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| Emmaus Life Sciences, Inc. | 29.59 Million USD | -20868.578% |
| Provectus Biopharmaceuticals, Inc. | 557.71 Thousand USD | -1112677.25% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -8865714.286% |
| THC Farmaceuticals, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 658.5 Thousand USD | -942355.581% |
| Alpha Cognition Inc. | - USD | -Infinity% |
| Enzolytics Inc. | 52.79 Thousand USD | -11754710.971% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 1.22 Billion USD | -406.074% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | 140.24 Thousand USD | -4425157.769% |
| Genscript Biotech Corporation | 839.52 Million USD | -639.232% |
| Nanobac Pharmaceuticals, Incorporated | 17.62 Thousand USD | -35219637.813% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | - USD | -Infinity% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| Cotinga Pharmaceuticals Inc. | - USD | -Infinity% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| PsyBio Therapeutics Corp. | - USD | -Infinity% |
| Adynxx, Inc. | - USD | -Infinity% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 997.72 Thousand USD | -621921.477% |
| EV Biologics, Inc. | 48.9 Thousand USD | -12691249.693% |
| Q BioMed Inc. | 284.35 Thousand USD | -2182430.807% |
| Capstone Therapeutics Corp. | 48.35 Million USD | -12734.657% |
| American Oriental Bioengineering, Inc. | 145.09 Million USD | -4177.11% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| BioStem Technologies, Inc. | 16.68 Million USD | -37094.602% |
| Curative Biotechnology, Inc. | - USD | -Infinity% |
| HST Global, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Halberd Corporation | 999.00 USD | -621228128.228% |
| Resverlogix Corp. | - USD | -Infinity% |
| Cell Source, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | -1005120.414% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Kadimastem Ltd | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| LadRx Corporation | - USD | -Infinity% |
| Regen BioPharma, Inc. | 236.56 Thousand USD | -2623365.506% |
| Affymax, Inc. | 1.36 Million USD | -453228.707% |
| Itoco Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| International Stem Cell Corporation | 7.78 Million USD | -79577.366% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| Bioxytran, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 473.73 Thousand USD | -1309943.696% |
| SYBLEU INC | 11.69 Thousand USD | -53061374.008% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | - USD | -Infinity% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 13 Thousand USD | -47738900.0% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | - USD | -Infinity% |
| Neutra Corp. | 39.53 Thousand USD | -15697957.368% |
| Windtree Therapeutics, Inc. | - USD | -Infinity% |
| PureTech Health plc | 3.33 Million USD | -186268.468% |
| Coeptis Therapeutics, Inc. | - USD | -Infinity% |
| IXICO plc | 6.66 Million USD | -93014.329% |
| IntelGenx Technologies Corp. | 1.03 Million USD | -597211.838% |
| Gelesis Holdings, Inc. | 25.76 Million USD | -23985.342% |
| CSL Limited | 14.8 Billion USD | 58.067% |
| Cellectis S.A. | 755 Thousand USD | -821896.026% |